JP3471318B2 - Syringe and container - Google Patents

Syringe and container

Info

Publication number
JP3471318B2
JP3471318B2 JP2000400690A JP2000400690A JP3471318B2 JP 3471318 B2 JP3471318 B2 JP 3471318B2 JP 2000400690 A JP2000400690 A JP 2000400690A JP 2000400690 A JP2000400690 A JP 2000400690A JP 3471318 B2 JP3471318 B2 JP 3471318B2
Authority
JP
Japan
Prior art keywords
cylinder
sealing plug
bypass
syringe
container
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP2000400690A
Other languages
Japanese (ja)
Other versions
JP2001212236A (en
Inventor
盛皓 須藤
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Daikyo Seiko Ltd
Original Assignee
Daikyo Seiko Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daikyo Seiko Ltd filed Critical Daikyo Seiko Ltd
Priority to JP2000400690A priority Critical patent/JP3471318B2/en
Publication of JP2001212236A publication Critical patent/JP2001212236A/en
Application granted granted Critical
Publication of JP3471318B2 publication Critical patent/JP3471318B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【発明の属する技術分野】本発明は薬液、栄養剤などを
人体に投与する注射器兼容器に関し、詳しくは注射器内
を二室に分離して各々に薬成分を保存しておき、投与の
際に二室の薬を速やかに混合し、極めて衛生的に投与で
きる注射器兼容器の改良に関する
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a syringe / container for administering a liquid medicine, a nutritional supplement, etc. to a human body. More specifically, the interior of the syringe is divided into two chambers to store the drug components in each chamber, and to administer the drug during administration. Improvement of syringe and container that can mix medicines in two chambers quickly and administer extremely hygiene

【0002】[0002]

【従来の技術】薬液、栄養剤などを予め注射器に充填
し、保管し、簡単な操作でその容器そのものが注射器と
なり得る、注射器兼容器としては、すでに実開昭57−
79539号、実開昭59−2343号、特開昭48−
76390号、特開昭48−16489号、特開昭52
−149894号、特開昭59−120166号、特開
昭60−501193号、特開昭61−502099
号、特開平1−502086号、特公昭62−2538
9号公報等が知られている。
2. Description of the Related Art A syringe can be filled with a drug solution, a nutrient, or the like in advance and stored, and the container itself can be a syringe by a simple operation.
No. 79539, No. 59-2343, U.S. Pat.
76390, JP-A-48-16489, JP-A-52.
No. 149894, JP-A-59-120166, JP-A-60-501193, and JP-A-61-502099.
No. 1, Japanese Unexamined Patent Publication No. 1-502086, Japanese Patent Publication No. 62-2538.
No. 9 publication is known.

【0003】さらに、一つの注射器兼容器内に二種類の
薬品、例えば薬品と溶剤又は薬液と薬液等を保存し、投
与の際に両者を混合又は溶解して投与できるようにした
注射器の従来例としては、特開昭51−11691号、
同52−22391号、同58−61755号、同58
−212453号、同59−155264号、同59−
155264号、同60−72561号、同61−48
377号、同62−5357号、特開平2−5973
号、同3−82476号、同4−96762号、実公昭
49−14465号、同54−22315号、実開平2
−58446号、同3−29145号の等の各公報に記
載の技術が知られている。
Further, a conventional example of a syringe in which two kinds of medicines, for example, medicines and solvents or medicinal solutions and medicinal solutions, are stored in a single injector / container and the two can be mixed or dissolved to be administered at the time of administration For example, JP-A-51-11169,
No. 52-22391, No. 58-61755, No. 58
-212453, 59-155264, 59-
155264, 60-72561, 61-48.
No. 377, No. 62-5357, JP-A-2-5973.
No. 3, No. 3-82476, No. 4-96762, No. 49-14465, No. 54-22315, No. 2
The techniques described in each publication such as -58446 and 3-29145 are known.

【0004】図15及び図16に公知の二室式注射器兼
容器の一例を示す。該注射器は、第1密封栓33を境と
して二室に分かれ、二室に保持する薬を用時に混合する
ことができる。即ち、筒29の一端は開口部31とな
り、その末端に指かけ用フランジ32を設けてある。他
の先端部30は細長くなっていて、先端はゴム栓で密封
されている。筒29内には第1密封栓33と第2密封栓
34が嵌着されていて、筒内を第1室35と第2室36
に分割して、図示の例では第1室35に粉末薬30を、
第2室36に蒸留水を保持している。また、筒29のほ
ぼ中央先端よりに1個のバイパス部37を設けてあり、
薬の溶解・混合の際には押し棒(図示せず)によって第
2密封栓34を先端側に移動し、蒸留水を介して第1密
封栓33を図中鎖線で示す先端側のバイパス部37の位
置に移動させることにより第2室36の蒸留水は第1室
35に流れ込んで第1室内の粉末薬30と混合され薬を
溶解して投与できる薬液となる。バイパス部のE−E′
断面は図16に示すように、筒外周と筒内壁は同じ厚さ
でバイパス部37において外側に突き出した形状に設計
されている。
15 and 16 show an example of a known dual-chamber syringe / container. The syringe is divided into two chambers with the first sealing plug 33 as a boundary, and the medicines held in the two chambers can be mixed at the time of use. That is, one end of the tube 29 becomes an opening 31, and a finger-holding flange 32 is provided at the end thereof. The other tip 30 is elongated and the tip is sealed with a rubber stopper. A first sealing plug 33 and a second sealing plug 34 are fitted in the cylinder 29, and a first chamber 35 and a second chamber 36 are fitted inside the cylinder.
In the illustrated example, the powder medicine 30 is divided into
Distilled water is held in the second chamber 36. Further, one bypass portion 37 is provided from the substantially central tip of the cylinder 29,
When the drug is dissolved / mixed, the second sealing plug 34 is moved to the tip side by a push rod (not shown), and the first sealing plug 33 is bypassed through distilled water to the tip side bypass portion shown by a chain line in the figure. By moving to the position of 37, the distilled water in the second chamber 36 flows into the first chamber 35 and is mixed with the powdered drug 30 in the first chamber to become a drug solution which can dissolve and administer the drug. By-pass EE '
As shown in FIG. 16, the cross section is designed such that the outer circumference of the cylinder and the inner wall of the cylinder have the same thickness and protrude outward in the bypass portion 37.

【0005】[0005]

【発明が解決しようとする課題】上記した従来技術はい
ずれも注射器中の二種の薬の混合手段の改良を主として
目的としており、同一形状容器の薬の製剤上の問題に関
しては全く考慮していない。即ち、図15、図16のよ
うな形態の注射器兼容器では、製剤工程等で容器を保管
する空間として必要な体積が非常に大きくなること、ま
た粉末薬を充填した後の第1密封栓の嵌着や、第2室に
蒸留水等を充填した後の第2密封栓の嵌着の作業性が良
くなく特に衛生上も好ましくないことなどの問題があっ
た。そこで、本発明の解決しようとする基本的課題は、
薬の製剤、薬の保存、薬の混合、更には薬の投与という
各段階において一つの容器内に薬を保持して操作できる
と共に、製造上も保存時も薬投与時も衛生的且つ安定し
て用いることのできる注射器兼容器の構造の改良にあ
る。また、他の課題として特に抗生物質、酵素、ビタミ
ン、血清、ワクチンなどの不安定な薬品の製造、保存、
投与に適した注射器兼容器の構造の改良がある。
All of the above-mentioned prior arts are mainly aimed at improving the mixing means of two kinds of drugs in a syringe, and completely consider the problem of formulation of drugs in the same shape container. Absent. That is, in the syringe / container having the configuration as shown in FIGS. 15 and 16, the volume required as a space for storing the container in the formulation process and the like becomes very large, and the first sealed stopper after filling the powder drug is used. There is a problem that the workability of fitting and fitting of the second sealing plug after filling the second chamber with distilled water or the like is not good and is not particularly hygienic. Therefore, the basic problem to be solved by the present invention is
The drug can be held and operated in one container at each stage of drug formulation, drug storage, drug mixing, and drug administration, and it is hygienic and stable during manufacturing, storage, and drug administration. There is an improvement in the structure of the syringe / container that can be used as a container. Another issue is the production and storage of unstable drugs such as antibiotics, enzymes, vitamins, serum, and vaccines.
There is an improvement in the structure of the syringe / container suitable for administration.

【0006】[0006]

【課題を解決するための手段】上記課題を解決するため
の手段として本発明は、一端に先端部を他端に開口部を
有する筒の略中央の位置の筒内壁面に筒長さ方向に走る
バイパスが設けられ、第1密封栓が該バイパスより筒開
口部寄りの位置において筒内面に嵌着されて筒先端部と
該第1密封栓との間に第1室を形成し、該第1密封栓よ
り筒開口部よりの位置において第2密封栓が筒内面に嵌
着されて該第1密封栓との間に第2室を形成した二室式
の注射器兼容器において、該バイパスは筒内壁面に凹形
溝状に1個又は複数個設けられ、筒外周は凹凸のない円
筒形状のものであり、上記第1密封栓の筒軸方向の厚さ
が上記第1バイパスの長さより短いものであり、且つ環
状オレフィン系化合物又は架橋多環式炭化水素系化合物
を重合体成分とする樹脂を含有する樹脂、又はオレフィ
ン系化合物を重合体成分とする樹脂、並びにこれらの樹
脂とオレフィン系樹脂及び/又は合成ゴムとの混合物か
らなることを特徴とする注射器兼容器を提供する。本発
明の注射器兼容器を、薬の製造工程においては内部に重
点した薬を乾燥または凍結真空乾燥した後速やかにその
室内にて密封するために、また薬の保存、薬の混合、更
には薬の投与に好適に用い得るために、上記第1密封栓
及び/または第2密封栓表面が樹脂フィルムにて積層さ
れてなること、上記筒の先端内部を円形底部にし、凹凸
ができないようにゴム栓で密封し、該ゴム栓に両頭針を
装着し、固定できる形状にされてなることを本発明の特
に好ましい実施態様として挙げることができる。また、
該筒の開口部の筒入口部分の壁厚さが筒内部の壁厚さよ
り薄くなっているものは密封栓の押し込みが容易であ
る。
As means for solving the above problems, the present invention is directed to a cylinder inner wall surface at a substantially central position of a cylinder having a tip portion at one end and an opening portion at the other end in a cylinder length direction. A bypass that runs is provided, and the first sealing plug is fitted to the inner surface of the cylinder at a position closer to the cylinder opening than the bypass to form a first chamber between the cylinder tip and the first sealing plug. In the two-chamber syringe / container in which the second sealing plug is fitted to the inner surface of the cylinder at a position closer to the opening of the cylinder than the first sealing plug to form the second chamber between the first sealing plug and the second chamber, One or a plurality of concave grooves are provided on the inner wall surface of the cylinder, and the outer circumference of the cylinder is a cylindrical shape without irregularities. The thickness of the first sealing plug in the cylinder axis direction.
Is shorter than the length of the first bypass and contains a resin containing a cyclic olefin compound or a crosslinked polycyclic hydrocarbon compound as a polymer component, or a resin containing an olefin compound as a polymer component And a mixture of these resins with an olefin resin and / or a synthetic rubber, and a syringe / container. In the manufacturing process of the drug, the syringe / container of the present invention is used for the purpose of preserving the drug, mixing the drug, and further preserving the drug in order to quickly seal the drug in the room after drying or freeze-vacuum drying the drug focused on the inside. The first sealing plug and / or the second sealing plug surface is laminated with a resin film so that it can be suitably used for administration of A particularly preferable embodiment of the present invention is that the rubber plug is sealed and the double-ended needle is attached to the rubber plug so that the rubber plug can be fixed. Also,
If the wall thickness of the cylinder inlet portion of the opening of the cylinder is smaller than the wall thickness inside the cylinder, the sealing plug can be easily pushed.

【0007】[0007]

【作用及び実施例】本発明の注射器兼容器の構造、作用
機構及びその他の特徴を実施例を挙げて詳細に説明す
る。図1は本発明の一実施例の概略断面図であって、注
射器兼容器1の注射筒(以下、筒という)2の中央ほぼ
先端よりの筒内面に、筒長さ方向に走るバイパス溝(以
下、第1バイパスという)11を設け、該第1バイパス
11の長さより短い長さの第1密封栓8を、該第1バイ
パス11より筒2の筒開口部5寄りに位置させ、第1密
封栓8と筒先端部との間に第1室7を形成した。該第1
密封栓8より筒開口部5寄りの位置の筒内に第2密封栓
10を嵌着して前記第1密封栓8と第2密封栓10との
間に第2室9を形成して、二室からなる筒、容器とし
た。第1密封栓8と第2密封栓10とは外周に複数の環
状突起を有する弾性体からなり、図示の例では3個の環
状突起19,20,21を有していて、該突起の外径は
筒内径より若干大きく設計し、筒内に嵌着すると、筒内
面と密着して室内を密封でき、その上筒内面を移動でき
るようにしてある。このために、該第1密封栓8または
第2密封栓10の表面を樹脂フィルムで積層することも
できる。また、第2密封栓10には筒開口部方向に螺旋
形の窪12を設け、該窪12は図2に示す押し棒の先端
の螺旋形の突起13に嵌合するように設計する。筒2の
上部開口部5の末端15は円筒壁を筒内径が開口部に向
かい大きくなるようにテーパを形成し、前記第1密封栓
または第2密封栓の筒内への挿入を容易になるように設
計した。
Actions and Examples The structure, action mechanism and other features of the syringe / container of the present invention will be described in detail with reference to examples. FIG. 1 is a schematic cross-sectional view of one embodiment of the present invention, in which a bypass groove running in the cylinder length direction is formed on the inner surface of the injection cylinder (hereinafter, referred to as a cylinder) 2 of a syringe / container 1 from a substantially central end thereof. Hereinafter, the first bypass 11 is provided, and the first sealing plug 8 having a length shorter than the length of the first bypass 11 is located closer to the tube opening 5 of the tube 2 than the first bypass 11 is. The first chamber 7 was formed between the sealing plug 8 and the tip of the cylinder. The first
A second sealing plug 10 is fitted into the cylinder at a position closer to the cylinder opening 5 than the sealing plug 8 to form a second chamber 9 between the first sealing plug 8 and the second sealing plug 10. A cylinder and a container consisting of two chambers were used. The first sealing plug 8 and the second sealing plug 10 are made of an elastic body having a plurality of annular protrusions on the outer circumference, and in the illustrated example, have three annular protrusions 19, 20 and 21. The diameter is designed to be slightly larger than the inner diameter of the cylinder, and when fitted inside the cylinder, it is in close contact with the inner surface of the cylinder to seal the inside of the chamber, and the inner surface of the cylinder can be moved. For this purpose, the surface of the first sealing plug 8 or the second sealing plug 10 may be laminated with a resin film. Further, the second sealing plug 10 is provided with a spiral recess 12 in the direction of the opening of the cylinder, and the recess 12 is designed to fit into the spiral projection 13 at the tip of the push rod shown in FIG. The end 15 of the upper opening 5 of the tube 2 is formed by tapering the cylindrical wall so that the inside diameter of the tube increases toward the opening, facilitating insertion of the first sealing plug or the second sealing plug into the tube. Designed to

【0008】図3、図6、図12はそれぞれ本発明の参
考例の概略説明図であって、これらの例では該筒2の第
2バイパス14のB−B′断面図を図5又は図13に示
すように設けてある。該第2バイパス溝の数は2〜8個
が好ましく、第1バイパス11は図4のA−A′断面図
に示すように、バイパス溝数1〜4個が好ましい。以上
の図に示した如く、本発明は注射筒の外表面に凸形を設
けることなく、筒内の内壁面に凹形の溝を設けた点、及
び特定の樹脂又は樹脂混合物で形成された点に特徴を有
する。
FIGS. 3, 6, and 12 are schematic explanatory views of reference examples of the present invention. In these examples, a sectional view of the second bypass 14 of the cylinder 2 taken along the line BB 'is shown in FIG. 5 or FIG. It is provided as shown in FIG. The number of the second bypass grooves is preferably 2 to 8, and the number of the first bypass 11 is preferably 1 to 4 as shown in the sectional view taken along the line AA 'of FIG. As shown in the above figures, the present invention is formed by forming a concave groove on the inner wall surface of the injection cylinder without forming a convex shape on the outer surface of the injection cylinder, and by forming a specific resin or resin mixture. It is characterized by points.

【0009】本発明において、図3に示すように筒2の
先端部3の内部に逆U字形ゴム栓4を装着してにて密封
し、かつ該ゴム栓4は筒2先端部3の内底に凹凸を設け
ないような形状にしてあり、針装着管6と共に両頭針1
6を先端に取り付け、固定できるようにすると共に、両
頭針16の内針先にて逆U字形ゴム栓4の中央を貫通し
得るような形状に設計したものも、特に好ましい実施態
様である。また、図6、図7も先端に両頭針16と逆U
字形ゴム栓を取り付けた本発明の参考例を示す。
In the present invention, as shown in FIG. 3, an inverted U-shaped rubber stopper 4 is mounted inside the tip portion 3 of the cylinder 2 for sealing, and the rubber stopper 4 is inside the tip portion 3 of the cylinder 2. It has a shape that does not have unevenness on the bottom, and double-ended needle 1 together with needle mounting tube 6.
A particularly preferable embodiment is one in which 6 is attached to the tip so as to be fixed, and the inner needle tip of the double-ended needle 16 is designed to penetrate through the center of the inverted U-shaped rubber stopper 4. 6 and 7, the double-ended needle 16 and the inverted U
The reference example of this invention which attached the V-shaped rubber stopper is shown.

【0010】本発明の注射器兼容器は図1に示す如く、
筒2の第1室7は濃縮薬または乾燥粉末薬の室とし、第
2室9には注射用蒸留水または希い薬液を充填し、第1
密封栓8にて分離し、第2密封栓10、ゴム栓4にて筒
2を密封し、2種類の薬を保存している。開口部または
両頭針をキャップ17にて包んで、エチレンオキサイド
ガス、γ線などにて殺菌し得るので、本発明は非常に衛
生的な注射器兼容器である。
The syringe / container of the present invention is as shown in FIG.
The first chamber 7 of the tube 2 is used as a concentrated drug or dry powder drug chamber, and the second chamber 9 is filled with distilled water for injection or a rare drug solution.
Separated with a sealing plug 8, the second sealing plug 10 and a rubber plug 4 seal the tube 2 to store two kinds of drugs. Since the opening or the double-ended needle can be wrapped with the cap 17 and sterilized with ethylene oxide gas, γ rays, etc., the present invention is a very hygienic syringe / container.

【0011】図3に筒開口部に付属する指かけフランジ
23を示す。即ち、開口部、外周凹部22に指かけ凹部
を嵌合して固定する。該器具は注射薬の投与の際や押し
棒を移動する際に指をかける器具である。筒とは別に構
成されていて製剤工程(充填、凍結乾燥)では用いない
ので、これらの工程において筒の外形はシンプルな円筒
形状を保てる。
FIG. 3 shows the finger hooking flange 23 attached to the cylindrical opening. That is, the finger hook concave portion is fitted and fixed to the opening and the outer peripheral concave portion 22. The device is a device to put a finger on when administering an injection drug or moving a push rod. Since it is configured separately from the cylinder and is not used in the formulation process (filling and freeze-drying), the outer shape of the cylinder can be kept simple in these processes.

【0012】図8,9は本発明の参考例であるが、薬の
製剤、即ち希い薬液を濃縮する、特に凍結真空乾燥製剤
に、本発明の注射器兼容器の使用が適した構造体である
ことを説明している。筒2の先端3をゴム栓4で密封
し、筒内に薬の原料である薄い薬液25の適当量を仕込
み、殺菌した乾燥室(真空にでき、入れ込む空気は殺菌
できる)において、不安定なる薬例えば抗生物質、酵
素、ビタミン類のような熱、酸素の影響をうけやすい薬
の製剤には原液を凍結して真空乾燥が行われ、その条件
は例えば室温度は−10〜−60℃、即ち液体窒素ガス
を使用しての冷却、真空度10-3〜10Torrと極め
て厳しい条件下での薬の濃縮、乾燥を行うのに好ましい
形状をしている。図8に示すように第2バイパスと筒2
開口部を接近させ、溝を2〜8本と多量に、またその面
積を広く設けてあり、そのバイパス中には多環状の厚い
第1密封栓が装入されているので、該第2バイパス14
を乾燥中に濃縮薬25の蒸気26が通過することは、蒸
留塔の効果を示すことになる。また第1密封栓より短い
第2バイパスにすると装置コストを低下できまた蒸気通
路を短くするので再析出等を防ぐことができる。
8 and 9 are reference examples of the present invention, a structure suitable for use of the syringe-cum-container of the present invention for a drug formulation, that is, for concentrating a rare drug solution, particularly for a freeze-vacuum dried formulation. Explain that there is. The tip 3 of the tube 2 is sealed with a rubber stopper 4, and the tube is charged with an appropriate amount of a thin drug solution 25, which is a raw material of the drug, and is unstable in a sterilized drying chamber (which can be evacuated and air to be sterilized). Drugs such as antibiotics, enzymes, vitamins and other drugs that are easily affected by heat and oxygen require freezing of the undiluted solution and vacuum drying. The conditions are, for example, room temperature of -10 to -60 ° C. That is, it has a preferable shape for cooling using liquid nitrogen gas, concentrating and drying the drug under a very severe condition of a vacuum degree of 10 −3 to 10 Torr. As shown in FIG. 8, the second bypass and the cylinder 2
Since the openings are made close to each other and a large number of grooves, such as 2 to 8, and the area thereof are wide, and the first annular sealing plug having a large annular shape is inserted in the bypass, the second bypass is used. 14
The passage of the vapor 26 of the concentrate 25 during the drying of the liquor indicates the effect of the distillation column. If the second bypass, which is shorter than the first sealing plug, is used, the cost of the apparatus can be reduced and the vapor passage can be shortened to prevent re-deposition.

【0013】また本発明の参考例においては第2バイパ
スの長さを第1密封栓の厚さより短く、かつ第1密封栓
の厚さの1/3〜等倍好ましくは1/2〜等倍とするこ
ともできる。図12の筒2は図8の第2バイパスの場合
の約1/2の長さの第2バイパスを有するが、図12の
例では第1密封栓は筒内壁に固定され、乾燥する蒸気2
6は図8の場合と同様にバイパス14を通り蒸発するこ
とができる。図13に図12のB−B′断面図を示す。
さらに図14に、第2バイパスの長さを第1密封栓の厚
さの約1/3より若干長い程度にした例を筒の中心軸に
垂直な面での断面と該断面のC−C′方向、D−D′方
向の筒軸方向部分断面図を示した。第2バイパスは短い
が図示のように筒内壁に十分固定され、薬の濃縮乾燥時
の蒸気は第2バイパス溝から排気できる。この例では排
気通路が短いので製造装置を小さくできるに加え、排気
等が再析出することがない。ただし第1密封栓の1/3
より短いバイパスにすると、乾燥室内で第1密封栓を第
2バイパスに押入れる作業や、乾燥時に筒内壁に該密封
栓を安定に保持することが困難になる。
Further, in the reference example of the present invention, the length of the second bypass is shorter than the thickness of the first sealing plug, and 1/3 to 1 times, preferably 1/2 to 1 times the thickness of the first sealing plug. Can also be The cylinder 2 in FIG. 12 has a second bypass having a length of about 1/2 of that in the case of the second bypass in FIG. 8, but in the example of FIG. 12, the first sealing plug is fixed to the inner wall of the cylinder and the steam 2 is dried.
6 can be evaporated through the bypass 14 as in the case of FIG. FIG. 13 is a sectional view taken along line BB ′ of FIG.
Further, FIG. 14 shows an example in which the length of the second bypass is slightly longer than about 1/3 of the thickness of the first sealing plug, and a cross section taken along a plane perpendicular to the central axis of the cylinder and CC of the cross section. A partial sectional view in the cylinder axis direction of the'direction and DD 'direction is shown. Although the second bypass is short, it is sufficiently fixed to the inner wall of the cylinder as shown in the figure, and the vapor at the time of concentration and drying of the drug can be discharged from the second bypass groove. In this example, since the exhaust passage is short, the manufacturing apparatus can be made small, and exhaust gas does not re-precipitate. However, 1/3 of the first sealing plug
With a shorter bypass, it becomes difficult to push the first sealing plug into the second bypass in the drying chamber and to stably hold the sealing plug on the inner wall of the cylinder during drying.

【0014】本発明の注射器兼容器が上記条件に適して
いる理由は以下のとおりである。 (1)筒2の外形は円形であって、第1バイパス、第2
バイパスを内壁に凹形窪みとして設けてあるため、例え
ば凍結乾燥室での処理の際、冷媒すなわち液体窒素の流
れが良好となり、また外形が円形である筒は網形固定具
で、相互に接触するように接近して配置することができ
るため、単位面積当たりの処理容器本数が最大になり、
従来のバイパス部が筒の外側に突き出したものと比べ多
量に乾燥室内に入れることができる。また装置建設経
費、製造単位コストなどの経済性が有利になる。 (2)筒2の先端3を丸底にし、注射針の窪を逆U字型
ゴム栓で密封し、できるだけ凹凸をなくした設計にし
た。即ち筒先端底に存在している薬液も、凍結しても速
やかに乾燥できる。 (3)筒2内の濃縮薬が十分濃縮乾燥されて粉薬になっ
た時に、当該乾燥室内で、図9に示すように第1密封栓
8を押入具28にて作動させ、筒2内の中央部、第1バ
イパス11の上部まで挿入することにより、乾燥粉末を
密封することができる。以上の構成により、乾燥室内、
特に凍結真空乾燥・殺菌室内にて、筒2内に第1密封栓
で注射薬を密封することができる。このような製剤工程
に必要なる条件を十分に満足できる。
The reason why the syringe / container of the present invention is suitable for the above conditions is as follows. (1) The outer shape of the cylinder 2 is circular, and the first bypass and the second
Since the bypass is provided as a concave recess in the inner wall, the flow of the refrigerant, that is, liquid nitrogen, is good, for example, during processing in the freeze-drying chamber, and the cylinders with a circular outer shape are mesh-shaped fixtures that contact each other. Since they can be arranged close to each other, the number of processing vessels per unit area is maximized,
A large amount of the bypass portion can be put in the drying chamber as compared with the conventional bypass portion protruding outside the cylinder. In addition, economic efficiency such as equipment construction cost and manufacturing unit cost becomes advantageous. (2) The tip 3 of the cylinder 2 has a round bottom, and the hollow of the injection needle is sealed with an inverted U-shaped rubber stopper to make the design as uneven as possible. That is, the chemical liquid existing at the bottom of the tip of the cylinder can be dried quickly even if frozen. (3) When the concentrated drug in the cylinder 2 is sufficiently concentrated and dried to become a powdered drug, the first sealing plug 8 is operated by the pushing tool 28 in the drying chamber as shown in FIG. By inserting the central part and the upper part of the first bypass 11, the dry powder can be sealed. With the above configuration,
Particularly, in the freeze-drying / sterilization chamber, the injection drug can be sealed in the cylinder 2 with the first sealing plug. The conditions required for such a formulation process can be sufficiently satisfied.

【0015】多くの薬のうち、空気中でも安定で、加熱
殺菌できる薬粉末については、単なる殺菌室内におい
て、本発明の筒2に第1バイパスのみを有する注射器に
おいては、濃縮粉末薬を第1室に、第2室には希釈薬又
は蒸留水の二薬を充填することができる容器になる。図
9の操作の工程で、第1密封栓8にて第1室を密封した
筒2を、該乾燥室外に出し、殺菌室にて筒2の第2室9
に希釈薬又は注射用蒸留水(以下、蒸留水と略す)を充
填し、速やかに、第2密封栓10を打栓し、さらにキャ
ップ17をつけて完成した製品になる。
Among many medicines, the medicine powder which is stable in the air and can be sterilized by heating is simply in the sterilization chamber, and in the syringe having only the first bypass in the cylinder 2 of the present invention, the concentrated powder medicine is stored in the first chamber. In addition, the second chamber becomes a container that can be filled with the diluting drug or the two drugs of distilled water. In the operation step of FIG. 9, the cylinder 2 whose first chamber is sealed by the first sealing plug 8 is taken out of the drying chamber, and the second chamber 9 of the cylinder 2 is disposed in the sterilization chamber.
It is filled with a diluent or distilled water for injection (hereinafter, abbreviated as distilled water), and the second sealing plug 10 is quickly capped, and a cap 17 is attached to complete the product.

【0016】本発明では、第1密封栓および第2密封栓
で筒内の二室に薬、蒸留水を完全に密封するために、該
栓の直径を筒内径より3〜14%太く設計することが好
ましい。また筒2の開口末端15は開口部に向かいテー
パ状に肉薄に、即ち内径を太くすることにより、第1密
封栓及び第2密封栓の該筒2内への挿入を容易にした。
In the present invention, the diameter of the stopper is designed to be 3 to 14% larger than the inner diameter of the cylinder in order to completely seal the medicine and the distilled water in the two chambers inside the cylinder with the first and second sealing plugs. It is preferable. Further, the opening end 15 of the tube 2 is tapered thin toward the opening, that is, the inner diameter is made thicker to facilitate the insertion of the first and second sealing plugs into the tube 2.

【0017】次に本発明の注射器兼容器内に保存した薬
品を投与する方法を具体的に説明する。図10に示すよ
うに本発明の注射器兼容器の参考例に充填された薬を使
用に際して、筒2の開口部5のキャップ17をはずし、
図3に示した指かけフランジ23を挿入する。次に図2
の押し棒先端螺旋部13を、筒2の第2密封栓10の凹
形螺旋12内に挿入し、押し棒を筒2の先端部3方向に
圧入すると第1密封栓8が第1バイパス11の位置に近
づき、蒸留水は第1バイパスを流れて、第1室7に入
り、濃縮薬又は粉末薬と蒸留水を混合して、希釈した投
与できる薬液になる。この時点で図11に示すように筒
先部3に位置するゴム栓4に両頭針16を挿入し、両頭
針16中の空気を除き、押し棒を筒先部に押し入れるこ
とにより希釈薬液を投与することができる。以上のよう
に、本発明の注射器兼容器は、簡単なる操作で、速やか
に且つ衛生的に薬液を調製し、直ちに投与できる注射器
兼容器である。
Next, the method for administering the drug stored in the syringe / container of the present invention will be described in detail. As shown in FIG. 10, when using the medicine filled in the reference example of the syringe / container of the present invention, the cap 17 of the opening 5 of the cylinder 2 is removed,
The finger hook flange 23 shown in FIG. 3 is inserted. Next in FIG.
When the push rod tip spiral portion 13 of is inserted into the concave spiral 12 of the second sealing plug 10 of the cylinder 2 and the push rod is pressed in the direction of the tip portion 3 of the cylinder 2, the first sealing plug 8 causes the first bypass 11 to pass. The distilled water flows through the first bypass, enters the first chamber 7, and mixes the concentrated drug or powdered drug with distilled water to become a diluted administrable liquid medicine. At this point, as shown in FIG. 11, the double-ended needle 16 is inserted into the rubber stopper 4 located at the barrel tip 3, the air in the double-ended needle 16 is removed, and the push rod is pushed into the barrel tip to administer the diluted drug solution. be able to. INDUSTRIAL APPLICABILITY As described above, the syringe / container of the present invention is a syringe / container capable of promptly and sanitarily preparing a medicinal solution and immediately administering it by a simple operation.

【0018】本発明の注射器兼容器に使用する注射筒の
素材としては、環状オレフィン系化合物又は架橋多環式
炭化水素系化合物を重合体成分とする樹脂を含有する樹
脂、又はオレフィン系化合物を重合体成分とする樹脂、
並びにこのような樹脂に更にオレフィン系樹脂及び/又
は合成ゴム類を混合してなる混合物を用いる。上記素材
に更に他の樹脂、例えばポリエチレン、ポリプロピレ
ン、ポリエチレンテレフタレート、エチレン−ビニルア
ルコール、エチレン−ビニル共重合体、エチレン−酢酸
ビニル共重合体、ナイロン及びアモルファスナイロン、
エチレンプロピレン共重合樹脂、ポリメチルペンテン、
エチレン−ブチル共重合体等を1層以上積層することも
できる。
The material of the syringe barrel used in the syringe / container of the present invention is a resin containing a resin containing a cyclic olefin compound or a crosslinked polycyclic hydrocarbon compound as a polymer component, or an olefin compound Resin as a coalescing component,
In addition, a mixture obtained by further mixing such an resin with an olefin resin and / or a synthetic rubber is used. In addition to the above materials, other resins such as polyethylene, polypropylene, polyethylene terephthalate, ethylene-vinyl alcohol, ethylene-vinyl copolymer, ethylene-vinyl acetate copolymer, nylon and amorphous nylon,
Ethylene propylene copolymer resin, polymethylpentene,
It is also possible to laminate one or more layers of ethylene-butyl copolymer and the like.

【0019】第1密封栓又は第2密封栓の部分はゴム弾
性を必要とするのでその素材としては、合成ゴム即ちイ
ソプレン、ポリブタジエン、エチレンプロピレンターポ
リマー、イソプレン−イソブチレン共重合体、熱可塑性
エラストマーなどの架橋体が耐熱性を有する点でも好ま
しい。更に、該密封栓の一部を積層する樹脂フィルムと
しては、フッ素系樹脂、環状オレフィン系化合物又は架
橋多環式炭化水素系化合物を重合体成分とする樹脂、汎
用オレフィン系化合物を重合体成分とする樹脂からなる
ものが好ましい。
Since the first sealing plug or the second sealing plug needs rubber elasticity, its material is synthetic rubber, that is, isoprene, polybutadiene, ethylene propylene terpolymer, isoprene-isobutylene copolymer, thermoplastic elastomer, etc. The crosslinked product is also preferable in that it has heat resistance. Further, as the resin film for laminating a part of the sealing plug, a fluororesin, a resin containing a cyclic olefin compound or a crosslinked polycyclic hydrocarbon compound as a polymer component, and a general-purpose olefin compound as a polymer component It is preferable to use a resin containing

【0020】[0020]

【発明の効果】本発明の二室式注射器兼容器は、(1)
注射筒のバイパス溝が筒外周に突起を形成することな
く、筒内に二段階に設けたことにより、薬の製剤室内に
おいて原薬液を濃縮、乾燥、粉末化し、速やかに該注射
器兼容器の室内に密封することができるので、衛生的で
経済的なる容器である。(2)第1バイパス、第1密封
栓、筒先端の形状が目的に合致するよう最適な形態に設
計して組み合わせてあるので、薄く、熱、空気で分解し
易い原薬も速やかに濃縮し、安定な高品位な薬に製剤す
ることができる効果を奏する。(3)本発明の注射器兼
容器は保持した薬物を高品位に長期に保存できる。
The two-chamber syringe / container of the present invention comprises (1)
By providing the bypass groove of the injection cylinder in two steps inside the cylinder without forming a protrusion on the outer periphery of the cylinder, the drug substance solution is concentrated, dried, and powdered in the drug preparation room, and the interior of the syringe and container is quickly It is a hygienic and economical container because it can be sealed in the container. (2) Since the shapes of the first bypass, the first sealing plug, and the tip of the cylinder are designed and combined in an optimal form to match the purpose, the drug substance that is thin and easily decomposed by heat and air can be quickly concentrated. It has the effect of being able to be formulated into a stable, high-quality drug. (3) The syringe / container of the present invention can retain a drug held therein in high quality for a long period of time.

【図面の簡単な説明】[Brief description of drawings]

【図1】は本発明の注射器兼容器の一実施例を説明する
概略断面図である。
FIG. 1 is a schematic cross-sectional view illustrating an embodiment of the syringe / container of the present invention.

【図2】は押し棒の説明図である。FIG. 2 is an explanatory diagram of a push rod.

【図3】は本発明の注射器兼容器の参考例を説明する概
略断面図である。
FIG. 3 is a schematic cross-sectional view illustrating a reference example of the syringe / container of the present invention.

【図4】は図1、図6の第1バイパス部分のA−A′断
面図である。
FIG. 4 is a sectional view taken along the line AA ′ of the first bypass portion in FIGS. 1 and 6.

【図5】は図1、図6の第2バイパス部分のB−B′断
面図である。
FIG. 5 is a sectional view taken along line BB ′ of the second bypass portion of FIGS. 1 and 6.

【図6】は本発明の注射器兼容器の他の参考例を説明す
る概略断面図である。
FIG. 6 is a schematic sectional view for explaining another reference example of the syringe / container of the present invention.

【図7】は図6に示した本発明の注射器兼容器に取り付
ける両頭針の断面図である。
FIG. 7 is a cross-sectional view of a double-ended needle attached to the syringe / container of the present invention shown in FIG.

【図8】は本発明の注射器兼容器を用いて薄い濃度の薬
液を濃縮する製剤状況を示す概略説明図である。
FIG. 8 is a schematic explanatory view showing a formulation state in which a drug solution having a low concentration is concentrated using the syringe / container of the present invention.

【図9】は図8の工程に続き筒の中に第1密封栓を押入
れた状態を示す概略説明図である。
9 is a schematic explanatory view showing a state where the first sealing plug is pushed into the cylinder subsequent to the step of FIG.

【図10】は本発明の注射器兼容器の使用に際して、押
し棒を押し込み、薬液、第1密封栓を圧入して薬液がバ
イパスを通り第1室に流入する状態を示す概略説明図で
ある。
FIG. 10 is a schematic explanatory view showing a state where the push rod is pushed in, the drug solution and the first sealing plug are press-fitted, and the drug solution flows into the first chamber through the bypass when the syringe / container of the present invention is used.

【図11】は本発明の注射器兼容器に両頭針を挿入して
薬液を投与する状態を示す概略説明図である。
FIG. 11 is a schematic explanatory view showing a state in which a double-ended needle is inserted into the syringe / container of the present invention to administer a drug solution.

【図12】は本発明の注射器兼容器の他の実施例であっ
て、図8の場合の約1/2長さの第2バイパスを設けた
例を説明する概略断面図である。
12 is a schematic cross-sectional view illustrating another embodiment of the syringe / container of the present invention, in which a second bypass having a length of about ½ of that in the case of FIG. 8 is provided.

【図13】は図12の第2バイパス部分のB−B′断面
図である。
13 is a sectional view taken along line BB ′ of the second bypass portion of FIG.

【図14】は本発明の注射器兼容器の他の参考例であっ
て、短い第2バイパスを設けた例を断面及び部分断面で
示す説明図である。
FIG. 14 is an explanatory view showing another reference example of the syringe / container of the present invention, showing an example in which a short second bypass is provided in a cross section and a partial cross section.

【図15】は従来の二室式注射器兼容器において、注射
筒外周に突出したバイパスを示す概略説明図である。
FIG. 15 is a schematic explanatory view showing a bypass projecting to the outer circumference of an injection cylinder in a conventional dual-chamber syringe / container.

【図16】は図14の従来の二室式注射器兼容器のE−
E′断面図である。
16 is an E-of the conventional dual-chamber syringe / container of FIG.
It is an E'sectional view.

【符号の説明】[Explanation of symbols]

1 注射器兼容器、 2 筒、 3 先端部、 4 ゴ
ム栓、 5 筒開口部、 6 針装着管、 7 第1
室、 8 第1密封栓、 9 第2室、 10第2密封
栓、 11 第1バイパス、 12 凹形螺旋、 13
凸形螺旋、14 第2バイパス、 15 開口部の末
端、 16 両頭針、 17 開口部又は先端キャッ
プ、 18 ゴムパッキン、 19 環状突起、 20
環状突起、 21 環状突起、 22 開口部外周の
窪み、 23 指かけフランジ、24 枠型固定具、
25 源の薄い薬液、 26 蒸気、 27 濃縮薬
(粉末薬)、 28 押し棒(乾燥室での第1密封栓の
筒内押入具)、 29 注射筒、 30 筒先端、 3
1 筒開口部、32 フランジ、 33 第1密封栓、
34 第2密封栓、 35 第一室、 36 第二
室、 37 バイパス。
1 Syringe / container, 2 cylinders, 3 tip part, 4 rubber stopper, 5 cylinder opening, 6 needle mounting tube, 7 1st
Chamber, 8 1st sealing plug, 9 2nd chamber, 10 2nd sealing plug, 11 1st bypass, 12 concave spiral, 13
Convex spiral, 14 second bypass, 15 end of opening, 16 double-ended needle, 17 opening or tip cap, 18 rubber packing, 19 annular protrusion, 20
Annular protrusions, 21 annular protrusions, 22 recesses on the outer circumference of the opening, 23 finger flanges, 24 frame type fixtures,
25 source thin chemical liquid, 26 vapor, 27 concentrated drug (powdered drug), 28 push rod (in-cylinder push-in device for the first sealing plug in the drying chamber), 29 injection barrel, 30 barrel tip, 3
1 tube opening, 32 flange, 33 first sealing plug,
34 2nd sealing stopper, 35 1st chamber, 36 2nd chamber, 37 Bypass.

フロントページの続き (56)参考文献 特開 昭62−252407(JP,A) 特開 平1−197511(JP,A) 特開 昭63−77456(JP,A) 特開 平4−322662(JP,A) 特開 昭57−22766(JP,A) 特開 昭59−5046(JP,A) 特開 昭62−139668(JP,A) 実開 平2−58446(JP,U) 実開 平4−77948(JP,U) 実公 昭4−3574(JP,Y1) 米国特許2549417(US,A) (58)調査した分野(Int.Cl.7,DB名) A61M 5/24 A61J 1/05 A61M 5/28 A61M 5/315 Continuation of the front page (56) Reference JP 62-252407 (JP, A) JP 1-197511 (JP, A) JP 63-77456 (JP, A) JP 4-322662 (JP , A) JP-A-57-22766 (JP, A) JP-A-59-5046 (JP, A) JP-A-62-139668 (JP, A) Actual flat 2-58446 (JP, U) Actual flat 4-77948 (JP, U) U.S. Pat. No. 4,3,574 (JP, Y1) US Patent 2549417 (US, A) (58) Fields investigated (Int.Cl. 7 , DB name) A61M 5/24 A61J 1 / 05 A61M 5/28 A61M 5/315

Claims (3)

(57)【特許請求の範囲】(57) [Claims] 【請求項1】 一端に先端部を他端に開口部を有する筒
の略中央の位置の筒内壁面に筒長さ方向に走るバイパス
が設けられ、第1密封栓が該バイパスより筒開口部寄り
の位置において筒内面に嵌着されて筒先端部と該第1密
封栓との間に第1室を形成し、該第1密封栓より筒開口
部よりの位置において第2密封栓が筒内面に嵌着されて
該第1密封栓との間に第2室を形成した二室式の注射器
兼容器において、該バイパスは筒内壁面に凹形溝状に1
個又は複数個設けられ、筒外周は凹凸のない円筒形状の
ものであり、上記第1密封栓の筒軸方向の厚さが上記第
1バイパスの長さより短いものであり、且つ環状オレフ
ィン系化合物又は架橋多環式炭化水素系化合物を重合体
成分とする樹脂を含有する樹脂、又はオレフィン系化合
物を重合体成分とする樹脂、並びにこれらの樹脂とオレ
フィン系樹脂及び/又は合成ゴムとの混合物からなるこ
とを特徴とする注射器兼容器。
1. A bypass running in the cylinder length direction is provided on a cylinder inner wall surface at a substantially central position of a cylinder having a tip portion at one end and an opening portion at the other end, and the first sealing plug is provided with the cylinder opening portion from the bypass. A first chamber is formed between the tip of the cylinder and the first sealing plug by being fitted to the inner surface of the cylinder at a position closer to the first sealing plug, and the second sealing plug is positioned at a position closer to the cylinder opening than the first sealing plug. In a two-chamber syringe / container fitted to the inner surface to form a second chamber between the first sealing plug and the bypass, the bypass has a concave groove shape on the inner wall surface of the cylinder.
One or a plurality of them are provided, and the outer circumference of the cylinder is a cylindrical shape without irregularities, and the thickness of the first sealing plug in the cylinder axis direction is the above
A resin containing a resin having a cyclic olefin compound or a crosslinked polycyclic hydrocarbon compound as a polymer component, or a resin having an olefin compound as a polymer component, which is shorter than one bypass length, and these A container that also serves as a syringe, characterized in that it is made of a mixture of the above resin and an olefin resin and / or synthetic rubber.
【請求項2】 上記第1密封栓及び/または第2密封栓
表面が樹脂フィルムにて積層されてなることを特徴とす
る請求項1に記載の注射器兼容器。
2. The first sealing plug and / or the second sealing plug.
Syringe and container according to claim 1 whose surface is characterized by Rukoto such is laminated with a resin film.
【請求項3】 上記筒の先端内部を円形底部にし、凹凸
ができないようにゴム栓で密封し、該ゴム栓に両頭針を
装着し、固定できる形状にされてなることを特徴とする
請求項1又は2に記載の注射器兼容器。
3. The inside of the tip of the cylinder has a circular bottom, and
Seal with a rubber stopper so that a double-ended needle cannot
The syringe / container according to claim 1 or 2 , characterized in that the container can be mounted and fixed .
JP2000400690A 1992-11-27 2000-12-28 Syringe and container Expired - Lifetime JP3471318B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2000400690A JP3471318B2 (en) 1992-11-27 2000-12-28 Syringe and container

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP31858392 1992-11-27
JP4-318583 1992-11-27
JP2000400690A JP3471318B2 (en) 1992-11-27 2000-12-28 Syringe and container

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP21294993A Division JP3172005B2 (en) 1992-11-27 1993-08-27 Syringe and container

Publications (2)

Publication Number Publication Date
JP2001212236A JP2001212236A (en) 2001-08-07
JP3471318B2 true JP3471318B2 (en) 2003-12-02

Family

ID=26569414

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000400690A Expired - Lifetime JP3471318B2 (en) 1992-11-27 2000-12-28 Syringe and container

Country Status (1)

Country Link
JP (1) JP3471318B2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4838955B2 (en) * 2001-08-21 2011-12-14 武田薬品工業株式会社 Two-chamber prefilled syringe
FR2890316B1 (en) * 2005-09-02 2007-10-05 Aguettant Soc Par Actions Simp SYRINGE FOR FILLING THEN STERILIZED BY STEAM AUTOCLAVING.
TW201735960A (en) * 2016-02-09 2017-10-16 賽諾菲阿凡提斯德意志有限公司 Two-chamber carpule
WO2022190982A1 (en) * 2021-03-08 2022-09-15 テルモ株式会社 Pre-filled syringe

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2549417A (en) * 1949-08-10 1951-04-17 Frederick M Turnbull Syringe ampoule
JPS5918427B2 (en) * 1979-10-09 1984-04-27 テルモ株式会社 gasket for syringe
JPS595046A (en) * 1982-06-30 1984-01-11 Touritsu Kogyo:Kk Production of medical rubber article
JPH043574Y2 (en) * 1985-03-05 1992-02-04
JPH0780973B2 (en) * 1986-04-26 1995-08-30 三井石油化学工業株式会社 Cyclic olefin-based random copolymer
JPS62139668A (en) * 1985-12-16 1987-06-23 株式会社大協精工 Laminated plug for syringe
JPH0741065B2 (en) * 1986-09-19 1995-05-10 株式会社大協精工 Medical and pharmaceutical rubber products
JP2647409B2 (en) * 1988-02-01 1997-08-27 三井石油化学工業株式会社 New olefin random copolymer
JPH0331302Y2 (en) * 1988-10-21 1991-07-03
DK0440846T3 (en) * 1990-02-07 1993-07-12 Vetter & Co Apotheker Double chamber syringe and application method
JP2533814Y2 (en) * 1990-11-19 1997-04-23 参天製薬株式会社 Two-component syringe

Also Published As

Publication number Publication date
JP2001212236A (en) 2001-08-07

Similar Documents

Publication Publication Date Title
JPH06209994A (en) Injector which serves also as container
JP2738512B2 (en) Syringe assembly
US3946732A (en) Two-chamber mixing syringe
US4758230A (en) Syringe barrel assembly
JP2801207B2 (en) Syringe and method of assembling syringe
JP2738513B2 (en) Syringe adapted for lyophilizing and returning the injectable medicament
US4639250A (en) Syringe barrel and hypodermic needle assembly
KR0150108B1 (en) Catridge assembly for a lyophilized compound forming a disposable portion of an injector pen and method for same
JP3803934B2 (en) Syringe barrel for lyophilization, reconstitution and administration
JPWO2005089837A1 (en) Prefilled syringe
US4581015A (en) Multimedication syringe
IE32725L (en) Syringe ampoule.
JP3471318B2 (en) Syringe and container
JP3982855B2 (en) Syringe combining two chambers
JP3117900B2 (en) Syringe and container
JP3015220B2 (en) Syringe and container
JP2001017546A (en) Drug solution dispensing device and method for manufacturing the same
JP4004106B2 (en) Chemical injection device
JP3015285B2 (en) Syringe and container
JP3607464B2 (en) Chemical injection device
JPH11332984A (en) Medicinal liquid-containing syringe
EP0728492B1 (en) Dual chamber internal by-pass syringe assembly
JP3015284B2 (en) Syringe and container
JPH0810325A (en) Injector and container in common use
JP3226451B2 (en) Syringe

Legal Events

Date Code Title Description
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20030902

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20080912

Year of fee payment: 5

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20080912

Year of fee payment: 5

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090912

Year of fee payment: 6

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090912

Year of fee payment: 6

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090912

Year of fee payment: 6

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100912

Year of fee payment: 7

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100912

Year of fee payment: 7

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110912

Year of fee payment: 8

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110912

Year of fee payment: 8

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120912

Year of fee payment: 9

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120912

Year of fee payment: 9

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120912

Year of fee payment: 9

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130912

Year of fee payment: 10

EXPY Cancellation because of completion of term